Product correctly added to cart.

discount label
Vps34-PIK-III
View 3D

Biosynth logo

Vps34-PIK-III

CAS: 1383716-40-2

Ref. 3D-IFC71640

5mgTo inquire
10mgTo inquire
25mgTo inquire
50mgTo inquire
100mgTo inquire
Estimated delivery in United States, on Monday 13 Jan 2025

Product Information

Name:
Vps34-PIK-III
Description:

Vps34-PIK-III is a molecule that is involved in lipid metabolism. It has been shown to promote neuronal cell death and induce cancer in mice. Vps34-PIK-III has also been shown to be effective against choroidal neovascularization, the development of new blood vessels in the eye that can cause blindness, through inhibition of vascular endothelial growth factor (VEGF). This molecule is currently being tested as an anticancer drug for leukemia. Vps34-PIK-III inhibits autophagy and causes iron homeostasis disorders by inhibiting ferritin synthesis. The pharmacological effects of Vps34-PIK-III have been studied in clinical trials on leukemic mice and human cells that were derived from leukemia patients.

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
319.36 g/mol
Formula:
C17H17N7
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-IFC71640 Vps34-PIK-III

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".